Thiogenesis Therapeutics, Corp. focuses on the development of therapies for rare diseases, particularly those related to lysosomal storage disorders and mitochondrial diseases. The company engages in drug development and clinical research, leveraging expertise in orphan diseases. It operates primarily in the biotechnology sector and serves patients with specific genetic and metabolic conditions. Thiogenesis is based in San Diego, California.
